The Division of Vascular/Interventional Radiology is dedicated full time to the mission of patient care and research for the development of interventional procedures.
Phase 3 Prospective, Randomized, Blinded, and Controlled Investigation of HepaSphere/QuadraSphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Carcinoma
The purpose of this study is to evaluate overall survival in patients treated with HepaSphere/QuadraSphere compared to conventional transarterial chemoembolization with particle PVA.
The Gore FREEDOM Study: GORE Flow Reversal System and GORE Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes
The objective of this study is to provide an ongoing evaluation of clinical outcomes associated with the GORE Flow Reversal System and the GORE Embolic Filter when used for embolic protection during carotid artery stenting.
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis--The ATTRACT Trial
The purpose of this study is to determine if the use of adjunctive Pharmacomechanical Catheter Directed Thrombolysis, which includes the intrathrombus administration of rt-PA--Activase (Alteplase),can prevent the post-thrombotic syndrome(PTS)in patients with symptomatic proximal deep vein thrombosis (DVT) as compared with optimal standard DVT therapy alone.
The purpose of this research study is to determine if the GORE® Carotid Stent is safe and works well when used to treat carotid artery stenosis. We have enrolled the first subject world-wide in this trial.
The purpose of this study is to evaluate the safety and effectiveness in preventing pulmonary embolism of the VenaTech Convertible Vena Cava Filter. This filter is different from other permanent vena cava filters in that when filtering is no longer needed, another procedure is performed so the filter can be 'converted' to an open position. This permanently implanted filter was developed as an alternative to temporary or removable filters since removal of the filter is not required.
more information on our ongoing research
efforts, contact our Research Coordinator at
(843) 792-1930 or send an email to email@example.com.